Data collection:
The inclusion criteries were;- Patients older than 18 years of age with
moderate / severe pneumonia hospitalized in our hospital with the
diagnosis of COVID-19 confirmed by PCR on nasopharyngeal swab, - Given
high-dose steroid therapy in clinical follow-up, (>250
mg/day methylprednisolone, 3 days) - Patients whose blood tests, X-ray
images, and thoracic computed tomography sections were accessible -
Patients with full access to the researched criteria on file or
computer. Patients whose criteria could not be reached on file or
computer were excluded from the study.
The reviewed and noted variables included patients’ demographic
characteristics, co-morbidities existing prior to the admission, time of
illness onset and hospital admission, radiology findings, laboratory
test results, medications and supportive care, further medical
applications, and clinical outcomes. Data on the type, maximum daily
dose, first started time, and duration of corticosteroids were
collected.